Robot-Assisted Radical Cystectomy and Urinary Diversion in
Bladder Cancer
Ashok K. Hemal and Mani Menon
Summary. The potential advantages of robot-assisted surgery can be utilized in complex and advanced uro-oncologic surgery. The technique of robot-assisted radical cystectomy (RRC) for patients with bladder cancer in males and females was developed based on principles of open and laparoscopic surgery with mod- ifications using the daVinci system. This procedure employs precise and rapid radical cystectomy with minimal blood loss. Urinary diversions such as ortho- topic neobladder or ileal conduit can be performed totally intracorporeally, or the bowel segment is exteriorized from the incision used to deliver the specimen and the orthotopic neobladder or ileal conduit is reconstructed. At this point in time, performing urinary diversion extracorporeally reduces operative time in comparison to performing the procedure totally intracorporeally.
Keywords. Robot-assisted cystectomy, Urinary diversion, Bladder cancer, Uro-oncologic surgery
Introduction
Carcinoma of the urinary bladder is the most common malignancy of the urinary tract and almost 25% of cases with newly diagnosed bladder cancer have muscle- invasive disease [1]. Radical cystectomy is the most effective mode of treatment for these patients. Open surgery has been the standard option for these patients but is associated with complications in up to 30% of cases [2–4]. Among the various methods of urinary diversion, ileal conduit is a standard and versatile option against which newer techniques including orthotopic neobladders can be compared. On the other hand, the high complication rates associated with urinary diversion into the rectum makes this option less desirable in a patient with a significant life expectancy [5].
119
Vattikuti Urology Institute, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit,
MI 48202, USA
Refinements in surgical technique with respect to continent orthotopic diver- sion, as well as the incorporation of nerve sparing for preservation of sexual function, have allowed not only effective cancer control but also significant improvements in the quality of life [6]. These advances in surgical technique and improved instrumentation have allowed complex surgeries such as radical prostatectomy to be performed laparoscopically and with more versatility and excellent outcome using robots [7,8]. Laparoscopic radical cystectomy has been well described in the literature with reconstruction of intracorporeal and extra- corporeal urinary diversions (Tables 1 and 2) [9–16].
Basillote et al. recently reported their cystectomy experience, comparing open surgery with laparoscopic assistance and creation of an ileal neobladder [17].
They found that patients experienced decreased postoperative pain and quicker recovery without a significant increase in operative time and intracorporeal urinary diversion, proving the possibility that it can be done purely laparoscop- ically [17]. However, despite the feasibility, the use of laparoscopy for cystectomy has been limited to very few centers across the world due to potential compli- cations and a steep learning curve [18]. The experience gained from robot- assisted laparoscopic radical prostatectomy by our team was used as an interface to develop the technique of robot-assisted radical cystectomy, based on anatomic delineation with incorporation of principles of open radical cystectomy. At the
Table 1. Laparoscopic radical cystectomy (LRC) and ileal conduit (IC) urinary diversion Puppo et al. [9] Hemal et al. [10] Gill et al. [11] Gupta et al. [12]
No. of cases 5 9 2 5
Procedure Lap.-assisted LRC + IC LRC + IC LRC + IC
transvaginal RC + IC
Urinary diversion Extracorporeal Extracorporeal Intracorporeal Intracorporeal (intra/
extracorporeal)
Operation time, h 7.2 (6–9) 6.48 (5–8.1) 10.8 (10–11.5) 7.5 (7–8) (range)
Blood loss (ml)/ 3 transfused 2–6 533.3 ml (300–800) 1100 (1000–1200) 360 (300–400)/nil
transfusion units transfused
Length of stay (days) 10.6 (8–18) 10.88 (8–21) 6 7 (6–22)
Time to oral intake 2–4 NS 4 3
(days)
Time to return to NS 26.44 NS 20 (13–35)
work (days)
Follow-up 10.8 19 NS 24
(months)
Complications None 3 minor, 4 major
aNone
bNS, not stated.
a
Minor: subcutaneous emphysema, Subacute intestinal obstruction (SAIO), deep vein thrombosis; major:
rectal tear (2), external iliac vein tear, hypercarbia.
b
One small bowel obstruction, one self-limiting abdominal distension.
time of writing our team has modest experience of 30 cases of robotic-assisted radical cystectomy procedures.
Surgical Technique
Patient Preparation and Port Placement
The patient presents on the morning of surgery after undergoing a formal bowel preparation. After the induction of general anesthesia, all upper extremity pres- sure points are padded and the patient is positioned in the extended lithotomy position.
The nuances of port placement have been recently described in detail [19]. In brief, to achieve transperitoneal access, pneumoperitoneum is created using a Veress needle in the supraumbilical region (Ethicon Endosurgery, Albuquerque, NM, USA). Upon insufflation to 15 mmHg, a 12-mm primary port is inserted and the peritoneal cavity is inspected with a 30° laparoscope. Two 8-mm robotic instrument ports are placed at the lateral edge of the rectus muscle at a point 2 cm below the umbilicus on each respective side. A second 12-mm port is placed in the right iliac fossa approximately 3 cm above the iliac crest. A 5-mm port is placed between the robotic and 12-mm port on right side and another 5-mm port is placed on the left side 3 cm above the iliac crest. The daVinci robot is then docked over the patient.
Dissection in Recto-Vesical Pouch
The laparoscope is positioned on the daVinci robot with the 30° lens angled downward. An inverted U-shaped incision is made in the peritoneum of the Table 2. Laparoscopic radical cystectomy (LRC) and continent diversion—orthotopic ileal neobladder (OIN)
Gaboardi et al. Gill et al. Simonato et al. Abdel-Hakim et al.
[13] [14] [15] [16]
No. of cases 1 2 6 8
Procedure LRC + OIN LRC + OIN LRC + OIN LRC + OIN
Intra/extracorporeal Intra + extra Intracorporeal Extracorporeal Extracorporeal
Operation time, h 7.5 9.5 (8.5–10.5) 7.1 8.3 (6.5–12)
(range)
Blood loss (ml) 350 300 (200–400) 310 (220–440) 150–500
Length of stay 7 8.5 (5–12) 8.1 (7–9) NS
(days)
Time to oral intake 2 2–4 3–5 3
(days)
Follow-up (months) 1–13 9.3 (5–15) NS
Complications None
aNone None
a